Form 4 Tracker
Avalo Therapeutics, Inc.
AVTX

51 insider filings · Latest: Aug 11, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 6, 2026May 6 8:29 PMMITCHELL CHAN
Proposed Sale
3,167$16.26$51.5K

View →

Apr 30, 2026May 1 8:37 PMChristopher Ryan SullivanChief Financial Officer
Sale
8,457$13.23$111.9K423(D)

View →

Apr 29, 2026May 1 8:37 PMChristopher Ryan SullivanChief Financial Officer
Sale
8,458$13.09$110.7K8,880(D)

View →

Apr 29, 2026Apr 29 8:33 PMCHRISTOPHER SULLIVAN
Proposed Sale
16,915$12.86$217.5K

View →

Apr 6, 2026Apr 8 8:51 PMMittie DoyleChief Medical Officer
Sale
3,970$18.01$71.5K3,622(D)

View →

Apr 6, 2026Apr 6 8:34 PMMITTIE DOYLE
Proposed Sale
65,800$17.76$1.2M

View →

Apr 2, 2026Apr 3 7:14 PMChristopher Ryan SullivanChief Financial Officer
Sale
7,980$17.15$136.8K17,338(D)

View →

Apr 1, 2026Apr 3 7:14 PMChristopher Ryan SullivanChief Financial Officer
Sale
7,979$16.77$133.8K25,318(D)

View →

Apr 1, 2026Apr 3 7:13 PMMittie DoyleChief Medical Officer
Sale
679$16.00$10.9K3,622(D)

View →

Apr 1, 2026Apr 1 8:48 PMCHRISTOPHER SULLIVAN
Proposed Sale
15,959$14.93$238.3K

View →

Mar 16, 2026Mar 18 8:07 PMMittie DoyleChief Medical Officer
Sale
25,492$16.15$411.6K3,622(D)

View →

Mar 16, 2026Mar 16 8:39 PMMITTIE DOYLE
Proposed Sale
29,529$15.80$466.6K

View →

← Previous

Page 2 of 2

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 5, 2026May 7 8:16 PMMittie DoyleChief Medical Officer
Option Exercise
1,679$12.65147,650(D)

View →

Apr 6, 2026Apr 8 8:51 PMMittie DoyleChief Medical Officer
Option Exercise
3,970$12.65210,530(D)

View →

Apr 1, 2026Apr 3 7:13 PMMittie DoyleChief Medical Officer
Option Exercise
679$8.04148,329(D)

View →

Mar 31, 2026Apr 1 8:05 PMRita JainDirector
Grant/Award
1,339$14.931,339(D)

View →

Mar 31, 2026Apr 1 8:05 PMKevin Robert LindDirector
Grant/Award
1,370$14.931,370(D)

View →

Mar 28, 2026Mar 31 8:14 PMSamantha TruexDirector
Option Exercise
3,1663,167(D)

View →

Mar 28, 2026Mar 31 8:12 PMAaron KantoffDirector
Option Exercise
3,1663,167(D)

View →

Mar 28, 2026Mar 31 8:12 PMGilla KaplanDirector
Option Exercise
3,1663,167(D)

View →

Mar 28, 2026Mar 31 8:11 PMGarry Arthur NeilDirector, Chief Executive Officer
Option Exercise
64,86664,867(D)

View →

Mar 28, 2026Mar 31 8:10 PMChristopher Ryan SullivanChief Financial Officer
Option Exercise
24,20024,200(D)

View →

Mar 28, 2026Mar 31 8:09 PMMitchell ChanDirector
Option Exercise
3,1663,167(D)

View →

Mar 28, 2026Mar 31 8:09 PMJonathan GoldmanDirector
Option Exercise
3,1663,167(D)

View →

Mar 16, 2026Mar 18 8:07 PMMittie DoyleChief Medical Officer
Option Exercise
25,492$12.65149,008(D)

View →

Feb 26, 2026Mar 2 9:24 PMPaul VarkiChief Legal Officer
Grant/Award
80,000$17.6480,000(D)

View →

Feb 26, 2026Mar 2 9:23 PMJennifer RileyChief Strategy Officer
Grant/Award
95,000$17.6495,000(D)

View →

Feb 26, 2026Mar 2 9:23 PMMittie DoyleChief Medical Officer
Grant/Award
105,000$17.64105,000(D)

View →

Feb 26, 2026Mar 2 9:22 PMTaylor BoydChief Business Officer
Grant/Award
95,000$17.6495,000(D)

View →

Feb 26, 2026Mar 2 9:22 PMChristopher Ryan SullivanChief Financial Officer
Grant/Award
105,000$17.64105,000(D)

View →

Feb 26, 2026Mar 2 9:20 PMGarry Arthur NeilDirector, Chief Executive Officer
Grant/Award
286,000$17.64286,000(D)

View →

← Previous

Page 2 of 2